Stevanato Group S.p.A. (STVN)
STVN trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1849853/000119312526091540/0001193125-26-091540-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), fiscal year ended 2025-12-31. Converted from EUR at 0.9048 per USD (today's ECB or Federal Reserve reference rate).
Profile
| Field | Value |
|---|---|
| Ticker | STVN on NYSE |
| Sector | Health Care |
| Industry | Medical/Dental Instruments |
| Country | Italy |
| IPO year | 2021 |
| SEC CIK | 0001849853 |
| SEC industry code | Surgical & Medical Instruments & Apparatus |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $1.3B |
| Net income | $154.6M |
| Operating income | $219.7M |
| Net margin | 11.8% |
| Operating margin | 16.8% |
| Revenue growth | +7.4% |
| Cash | $144.3M |
| Total assets | $2.8B |
| P/E (computed) | 27.4× |
| P/S (computed) | 3.2× |
Reported in EUR; shown in US dollars.
Warning signs
| Sign | Finding | Source |
|---|---|---|
| Going concern | No going-concern finding. | 20-F 2026-03-04 |
| Cash and burn | 130.6M EUR cash; operating cash flow 71.5M EUR a quarter. | Report 2025-12-31 |
| Shares outstanding | 302,842,536 (2025-12-31); 302,842,536 a year earlier; 295,540,036 three years earlier. the newest SEC cover-page count is from 2025-12-31; shares issued since then are not in these figures. | Cover page 2025-12-31 |
| Reverse splits, 3 years | None found | None on EDGAR |
| Shelf and offerings, 12 months | 0 S-3/F-3 shelf filings; 0 424B5 takedowns | None on EDGAR |
| Exchange deficiency notices, 12 months | None | None on EDGAR |
| Auditor | PricewaterhouseCoopers spa, Treviso, Italy | PCAOB Form AP 2026-03-23 |
| Late filings, 12 months | None | None on EDGAR |
| Insider trades, 12 months | Bought $0, sold $485K on the open market | SEC Forms 3/4/5 data sets 2026-09-30 |
From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.
Annual results
| Fiscal year | Revenue | Net income | Op. cash flow | Cash | Total debt | TTM revenue | Source |
|---|---|---|---|---|---|---|---|
| FY 2025 2025-12-31 | 1.2B EUR | 139.8M EUR | 286.1M EUR | 130.6M EUR | 455.1M EUR | 1.2B EUR | 20-F 2026-03-04 |
| FY 2024 2024-12-31 | 1.1B EUR | 117.8M EUR | 155.8M EUR | 98.3M EUR | 412.1M EUR | 1.1B EUR | 20-F 2026-03-04 |
| FY 2023 2023-12-31 | 1.1B EUR | 145.6M EUR | 105.2M EUR | 69.6M EUR | 377.6M EUR | 1.1B EUR | 20-F 2026-03-04 |
| FY 2022 2022-12-31 | 983.7M EUR | 142.8M EUR | 103.3M EUR | 228.7M EUR | 197.5M EUR | 983.7M EUR | 20-F 2025-03-06 |
| FY 2021 2021-12-31 | 843.9M EUR | 134.3M EUR | 133.3M EUR | 411.0M EUR | 220.2M EUR | 843.9M EUR | 20-F 2024-03-07 |
| FY 2020 2020-12-31 | 662.0M EUR | 78.5M EUR | 155.7M EUR | 115.6M EUR | 336.4M EUR | 662.0M EUR | 20-F 2023-03-02 |
| FY 2019 2019-12-31 | 536.5M EUR | 39.2M EUR | 42.6M EUR | 85.4M EUR | No debt tags | 536.5M EUR | 20-F/A 2022-04-05 |
From SEC XBRL company facts (annual reports only: 20-F or 40-F). Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months). Amounts in EUR.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2024-03-25 |
| Latest annual report | 20-F | 2026-03-04 |
| Latest quarterly / interim | 6-K | 2026-11-12 |
Source: SEC EDGAR submissions feed, 222 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +16.4% |
| 1 month | -18.0% |
| 3 months | -26.6% |
| Year to date | -21.5% |
| 1 year | -30.3% |
| From 52-week high | -32.6% |
Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Medical/Dental Instruments
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| HTFL | Heartflow Inc. | $46.86 | -3.30% | $4.1B |
| ICUI | ICU Medical Inc. | $181.87 | +1.45% | $4.5B |
| NVST | Envista Holdings Corporation | $24.03 | -1.88% | $3.9B |
| MMSI | Merit Medical Systems Inc. | $86.35 | -0.32% | $5.2B |
| MMED | MiniMed Group Inc. | $18.65 | +3.67% | $5.2B |
| PLSE | Pulse Biosciences Inc Common Stock (DE) | $46.36 | -8.09% | $3.4B |
| HAE | Haemonetics Corporation | $121.34 | -1.30% | $5.5B |
| IRTC | iRhythm Holdings Inc. | $90.83 | -1.18% | $3.1B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier